AbbVie Highlights Innovative Research From Its Rheumatology Portfolio at ACR Convergence 2021
Thirty-eight abstracts underscore AbbVie’s commitment to advancing its portfolio of medicines to help more people living with rheumatic diseases NORTH CHICAGO, Ill. – AbbVie (NYSE: ABBV) today announced the presentation of… Read More




